comparemela.com

Latest Breaking News On - Tandem diabetes - Page 1 : comparemela.com

Q2 2024 EPS Estimates for Tandem Diabetes Care, Inc. Reduced by Analyst (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q2 2024 earnings estimates for Tandem Diabetes Care in a research note issued to investors on Tuesday, May 28th. Leerink Partnrs analyst M. Kratky now expects that the medical device company will post earnings of ($0.53) per share for […]

United-states
Leerink-partnrs
Robertw-baird
Stifel-nicolaus
Lisanti-capital-growth
Barclays
Charles-schwab-investment-management-inc
Raymond-james-associates
Russell-investments-group-ltd
Tandem-diabetes-care-inc
Nasdaq
Tandem-diabetes-care

At US$51.23, Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Worth Looking At Closely?

Tandem Diabetes Care, Inc. ( NASDAQ:TNDM ), might not be a large cap stock, but it saw a significant share price rise.

Tandem-diabetes
Tandem-diabetes-care

PayPal upgraded, UiPath downgraded: Wall Street's top analyst calls

PayPal upgraded, UiPath downgraded: Wall Street's top analyst calls
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
William-blair
Redburn-atlantic
Zimmer-biomet
Becton-dickinson
Piper-sandler
Cava-group
Wells-fargo
Goldman-sachs
Wall-street

Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM

29.05.2024 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) . Seite 1

United-states
Jake-leach
John-sheridan
Tandem-mobi
Tandem-diabetes-care
Glucose-monitoring
Business-wire
Tandem-diabetes

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have earned an average rating of “Moderate Buy” from the eleven analysts that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month […]

United-states
Stifel-nicolaus
Leerink-partnrs
Nasdaq
Wells-fargo-company
Jennison-associates
Tandem-diabetes-care-inc
Gwk-investment-management
Tandem-diabetes-care
Get-free-report
Wells-fargo
Diabetes-care

vimarsana © 2020. All Rights Reserved.